These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33022455)

  • 1. Adjuvant therapies for MRONJ: A systematic review.
    Govaerts D; Piccart F; Ockerman A; Coropciuc R; Politis C; Jacobs R
    Bone; 2020 Dec; 141():115676. PubMed ID: 33022455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
    Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
    J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
    Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
    Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis.
    Momesso GAC; Lemos CAA; Santiago-Júnior JF; Faverani LP; Pellizzer EP
    Oral Maxillofac Surg; 2020 Jun; 24(2):133-144. PubMed ID: 32056052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous platelet concentrates in treatment of medication related osteonecrosis of the jaw.
    Rusilas H; Balčiūnaitė A; Žilinskas J
    Stomatologija; 2020; 22(1):23-27. PubMed ID: 32706343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review.
    Goker F; Grecchi E; Grecchi F; Francetti L; Del Fabbro M
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2662-2673. PubMed ID: 33829453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
    Kuroshima S; Sasaki M; Murata H; Sawase T
    Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review.
    Fortunato L; Bennardo F; Buffone C; Giudice A
    J Craniomaxillofac Surg; 2020 Mar; 48(3):268-285. PubMed ID: 32063481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-related Osteonecrosis of the Jaw Induced by Regenerative Therapy in Implant Dentistry: A Scoping Review.
    Al-Omari FA; Kuroshima S; Sawase T
    J Dent; 2023 Nov; 138():104682. PubMed ID: 37708930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment methods of medication-related osteonecrosis of the jaw. A systematic review.
    Zigmantavičius J; Kilinskaitė G; Kubilius R
    Stomatologija; 2022; 24(4):91-99. PubMed ID: 37154420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of segmental mandibular resection without microvascular reconstruction in patients affected by medication-related osteonecrosis of the jaw: a systematic review.
    Sacco R; Umar G; Guerra RC; Akintola O
    Br J Oral Maxillofac Surg; 2021 Jul; 59(6):648-660. PubMed ID: 34023155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review.
    Lopez-Jornet P; Sanchez Perez A; Amaral Mendes R; Tobias A
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1067-72. PubMed ID: 27318752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review.
    Scribante A; Ghizzoni M; Pellegrini M; Pulicari F; Spadari F
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241204
    [No Abstract]   [Full Text] [Related]  

  • 18. Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).
    Nica DF; Riviș M; Roi CI; Todea CD; Duma VF; Sinescu C
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562600
    [No Abstract]   [Full Text] [Related]  

  • 19. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
    Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.